ALBUMIN (HUMAN)- albumin human solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

ALBUMIN (HUMAN) (UNII: ZIF514RVZR) (ALBUMIN (HUMAN) - UNII:ZIF514RVZR)

Pieejams no:

Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.

SNN (starptautisko nepatentēto nosaukumu):

ALBUMIN - UNII:ZIF514RVZR)

Kompozīcija:

ALBUMIN (HUMAN) 250 g in 1000 mL

Ievadīšanas:

Intravenous

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

ALBUMIN (HUMAN) 25% is indicated in the emergency treatment of hypovolemia with or without shock. Its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. It is most effective in patients who are well hydrated. When blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] When hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] For subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, ALBUMIN (HUMAN) 25% infusions may be indicated. [ 3 ] When albumin deficit is the result of excessive protein loss, the effect of administration of ALBUMIN (HUMAN) 25% will be temporary unless the underlying disorder is reversed. ALBUMIN (HUMAN) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui

Produktu pārskats:

ALBUMIN (HUMAN) 25% is supplied in 12.5 g in 50 mL or 25.0 g in 100 mL single use bottles. Octapharma Pharmazeutika Produktionsges.m.b.H Octapharma AB 67467-643-01 68209-643-01 50 ml 12.5 67467-643-02 68209-643-02 100 ml 25.0 ALBUMIN (HUMAN) 25% may be stored for 36 months at +2°C to + 25°C (36°F to 77°F) from the date of manufacture. Store protected from light. Do not freeze. Do not use after expiration date. Do not use if turbid.

Autorizācija statuss:

Biologic Licensing Application

Produkta apraksts

ALBUMIN (HUMAN)- ALBUMIN HUMAN SOLUTION
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGESELLSCHAFT M.B.H.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ALBUMIN (HUMAN) 25% SAFELY AND
EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ALBUMIN (HUMAN) 25%.
ALBUMIN (HUMAN) 25%
FOR INTRAVENOUS USE ONLY
25% SOLUTION
INITIAL U.S. APPROVAL: 2006
INDICATIONS AND USAGE
•ALBUMIN (HUMAN) 25% is indicated for the restoration and
maintenance of circulating blood volume for: (1)
•Hypovolemia. (1.1) (1)
•Hypoalbuminemia. (1.2) (1)
•Prevention of central volume depletion after paracentesis due to
cirrhotic ascites. (1.3) (1)
•Ovarian hyperstimulation syndrome (OHSS). (1.4) (1)
•Adult respiratory distress syndrome (ARDS). (1.5) (1)
•Acute nephrosis. (1.6) (1)
•Hemolytic disease of the newborn (HDN). (1.7) (1)
DOSAGE AND ADMINISTRATION
•Intravenous use only. (2)
•Daily dose should not exceed 2 g per kg body weight. (2.1) (2)
• (2)
INDIC ATIO N
DO SE
Hypovolemia (2)
Adults: 25 g (2)
Children (less than 13 years): 2.5 to 1.25 g to children (2.1) (2)
Hypoalbuminemia (2)
Adults: 50 to 75 g (2.1) (2)
Prevention of volume depletion after
paracentesis (2)
Adults: 8 g for every 1,000 mL of ascitic fluid removed (2.1) (2)
Ovarian hyperstimulation syndrome (2)
Adults: 50 to 100 g over 4 hours and repeated at 4-12 hour intervals
as
necessary (2.1) (2)
Adult respiratory distress syndrome (2)
Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if
necessary
(2.1) (2)
Acute nephrosis (2)
Adults: 25 g together with diuretic once a day for 7-10 days (2.1) (2)
Hemolytic Disease of the Newborn (2)
1 g per kilogram body weight prior or during exchange transfusion
(2.1) (2)
•Do not dilute with sterile water for injection as this may cause
hemolysis in recipients. (5.6) (2)
•Store protected from light. (16) (2)
•Do not freeze. (16) (2)
•If large volumes (greater than 1500 ml) are administered, warm the
product to room temperature before use. (2.2) (2)
�